Lv1
48 积分 2025-07-28 加入
‘Missing’ disease-causing variants in Alport syndrome
4个月前
已完结
Iptacopan in IgA Nephropathy — Final 24-Month Data
4个月前
已关闭
Inaxaplin for the treatment of APOL1-associated kidney disease
6个月前
已关闭
Myasthenia gravis
7个月前
已完结
Myasthenia gravis
7个月前
已关闭
Pharmacokinetics and Absorption, Distribution, Metabolism and Excretion of RGLS4326 in Mouse and Monkey, an Anti-miR-17 Oligonucleotide for the Treatment of Polycystic Kidney Disease
8个月前
已完结
Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
9个月前
已完结
The evolution of the obesity drug market
10个月前
已完结
Polycystic kidney disease
10个月前
已关闭
Autosomal Dominant Polycystic Kidney Disease
10个月前
已完结
皖公网安备34019202002308
